---
figid: PMC6517498__fimmu-10-01011-g0003
figtitle: Model of regulation of inflammasome activation by type I IFNs in Ehrlichia
  infection
organisms:
- Escherichia coli
- Mycobacterium tuberculosis
- Salmonella enterica subsp. enterica serovar Typhimurium
- Listeria monocytogenes
- Chlamydia trachomatis
- Citrobacter rodentium
- Francisella tularensis
- Brucella abortus
- Streptococcus sp. group B
- Anaplasma phagocytophilum
- Ehrlichia chaffeensis
- Rickettsia conorii
- Ehrlichia muris
- Francisella tularensis subsp. tularensis
- Ehrlichia canis
- Rickettsia parkeri
- Ehrlichia ewingii
- Rickettsia montanensis
- Rickettsia australis
- Ehrlichia chaffeensis str. Wakulla
- Rickettsia amblyommatis
- Canis lupus familiaris
- Sus scrofa
- Odocoileus virginianus
- Amblyomma americanum
- Rhipicephalus sanguineus
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Rana japonica
pmcid: PMC6517498
filename: fimmu-10-01011-g0003.jpg
figlink: /pmc/articles/PMC6517498/figure/F3/
number: F3
caption: 'Model of regulation of inflammasome activation by type I IFNs in Ehrlichia
  infection. During Ehrlichia infection, type I IFNs are thought to regulate inflammasome
  activation under a non-canonical fashion. Initially, Ehrlichia invade the target
  cell and induce TLR9/MyD88 signaling to upregulate NRLP3 complexes, pro-IL1β and
  pro-IL-18 via NF-κB. Type I IFNs from autocrine or paracrine sources would signal
  through IFNAR to upregulate GBPs and caspase-11. GBPs would disrupt vesicles containing
  Ehrlichia allowing the escape of ehrlichial PAMPs to the cytosol. Ehrlichial PAMPs
  would bind caspase-11 and subsequently induce inflammasome activation followed by
  secretion of mature IL-1β and IL-18 (as in the canonical pathway) and cleavage of
  gasdermin D resulting in pyroptosis. Direct arrow: positive regulation; blocking
  arrow: negative regulation; question mark (?) means hypothetical, and not experimentally
  proven.'
papertitle: Emerging Roles of Autophagy and Inflammasome in Ehrlichiosis.
reftext: Tyler R. Tominello, et al. Front Immunol. 2019;10:1011.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9463628
figid_alias: PMC6517498__F3
figtype: Figure
organisms_ner:
- Sus scrofa
- Canis lupus familiaris
- Odocoileus virginianus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC6517498__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6517498__fimmu-10-01011-g0003.html
  '@type': Dataset
  description: 'Model of regulation of inflammasome activation by type I IFNs in Ehrlichia
    infection. During Ehrlichia infection, type I IFNs are thought to regulate inflammasome
    activation under a non-canonical fashion. Initially, Ehrlichia invade the target
    cell and induce TLR9/MyD88 signaling to upregulate NRLP3 complexes, pro-IL1β and
    pro-IL-18 via NF-κB. Type I IFNs from autocrine or paracrine sources would signal
    through IFNAR to upregulate GBPs and caspase-11. GBPs would disrupt vesicles containing
    Ehrlichia allowing the escape of ehrlichial PAMPs to the cytosol. Ehrlichial PAMPs
    would bind caspase-11 and subsequently induce inflammasome activation followed
    by secretion of mature IL-1β and IL-18 (as in the canonical pathway) and cleavage
    of gasdermin D resulting in pyroptosis. Direct arrow: positive regulation; blocking
    arrow: negative regulation; question mark (?) means hypothetical, and not experimentally
    proven.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL18
  - IL1B2
  - TLR9
  - MYD88
  - IFNAR1
  - IFNAR2
  - IL1B
  - IFNA1
  - HADHA
  - LGALS1
  - PIAS1
  - TMEM132A
  - NFKB1
  - Il18
  - Il1b
  - Lgals3
  - Pias1
  - Tlr9
  - Myd88
  - Nfkb1
  - Ifnar1
  - Ifnar2
  - 'N'
---
